Information for Distributors
We are committed to helping distributors grow confidently within their markets.
Partner with Dunbar Pharmaceuticals
At Dunbar Pharmaceuticals, we specialise in producing pharmaceutical-grade, plant-derived cannabinoid APIs. As a trusted manufacturer focused on patient safety, innovation, regulatory compliance, and technical precision, we are committed to helping distributors grow confidently within their markets.
Dunbar Pharma
Why Partner with Dunbar Pharma?
100% Plant-Based Dronabinol API
Derived entirely from natural cannabis biomass -meeting growing patient and pharmacist demand for naturally sourced, GMP products.
Market-Leading Purity
Our dronabinol is among the purest on the market, meeting or exceeding DAC/NRF standards for pharmaceutical formulation. Our advanced production processes deliver a high purity, clear dronabinol.
Regulatory Excellence
Full traceability from starting material to final syringe. Every shipment includes COAs, validation for test strips, and insurance reimbursement data support – ensuring pharmacists have what they need for confidence and compliance.
Export-Ready & Licensed
Fully certified for export, with licensing frameworks expanding across the EU.
Pharmacist Support Kits
Distributors receive access to complete pharmacist support kits for their clients. These include regulatory documents, usage guidance, and onboarding materials to streamline implementation and pharmacist adoption.
In-House QC & QA Release
All testing and release are performed internally at our EU GMP-certified facility, including validated stability programs and batch release protocols – ensuring every shipment meets the highest standards.
Dunbar Dronabinol
Dunbar Pharma’s dronabinol API is currently available, delivered in pre-filled syringe format and housed in secure packaging. Each box contains a single 1000mg syringe, internally stabilised for transit and shelf storage. Each unit contains a pharmacist instruction leaflet.
Our dronabinol is produced at our EU GMP-certified facility in Ireland, with rigorous in-house quality control and batch release testing to ensure consistent potency, purity, and safety.
Growing With You
Our R&D and GMP teams are continually developing new cannabinoid-based APIs to expand your product portfolio and meet future patient and market needs.
Interested in becoming a distribution partner?